Literature DB >> 32162125

SAGES TAVAC safety and efficacy analysis WATS3D (CDx Diagnostics, Suffern, NY).

Salvatore Docimo1, Mazen Al-Mansour2, Shawn Tsuda3.   

Abstract

BACKGROUND: Wide-area transepithelial sampling of the esophagus with computer-assisted three-dimensional analysis (WATS3D, CDx Diagnostics, Suffern, NY) is an adjunctive technique to random biopsies for early detection of Barrett's esophagus. The aim of the SAGES Technology and Value Assessment Committee aims is to evaluate the efficacy, value, and safety of WATS3D.
METHODS: Clinical studies involving WATS3D were identified via a search of the PubMed/Medline databases ( www.ncbi.nlm.nih.gov/pubmed ) conducted in March of 2019 using search terms, such as wide-area transepithelial sampling, three-dimensional (3D) computer-assisted analysis, WATS-3D, Barrett's esophagus and WATS-3D, Barrett's esophagus and wide-area transepithelial sampling with three-dimensional computer-assisted analysis, Barrett's esophagus, and emerging technology. Bibliographies of key references were searched for relevant studies not covered by the PubMed search. Case reports and small case series were excluded.
RESULTS: No significant morbidity or mortality was reported within the literature associated with the WATS3D technology. WATS3D increases diagnostic yield by 38-150% for Barrett's Esophagus, by 40-150% for Low Grade Dysplasia; and by 420% for High Grade Dysplasia; when compared to forceps biopsy alone. WATS3D technique has very high inter-observer agreement for the pathological diagnosis of non-dysplastic and dysplastic Barrett's Esophagus. Increased detection of pre-malignant diseases of the esophagus by the adjunctive use of WATS3D supports screening and surveillance by the adjunctive use of WATS3D during upper endoscopy in appropriate patients.
CONCLUSION: Wide-area transepithelial sampling with three-dimensional computer-assisted analysis (WATS3D, CDx Diagnostics) is a safe and effective adjunct to forcep biopsies in the evaluation of Barrett's Esophagus, Low Grade Dysplasia, and High Grade Dysplasia.

Entities:  

Keywords:  Barrett’s esophagus and WATS-3D; Barrett’s esophagus and emerging technology; Barrett’s esophagus and wide-area transepithelial sampling with three-dimensional computer-assisted analysis; Three-dimensional (3D) computer-assisted analysis; WATS-3D; Wide-area transepithelial sampling

Mesh:

Year:  2020        PMID: 32162125     DOI: 10.1007/s00464-020-07503-w

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  4 in total

1.  WATS3D versus forceps biopsy in screening for Barrett's esophagus: experience in community endoscopy centers.

Authors:  Yasmine Hussein Agha; Sachin Srinivasan; Jeffrey Hyder; Chelsea Wuthnow; Ali Taleb; Nathan Tofteland; William Kilgore; William Salyers
Journal:  Ann Gastroenterol       Date:  2020-12-07

2.  Retrospective, observational, cross-sectional study of detection of recurrent Barrett's esophagus and dysplasia in post-ablation patients with adjunctive use of wide-area transepithelial sample (WATS-3D).

Authors:  Hala Fatima; Maryiam Wajid; Nour Hamade; Yan Han; William Kessler; John Dewitt; Douglas Rex; Thomas Imperiale
Journal:  Ann Gastroenterol       Date:  2022-01-07

3.  Wide-area transepithelial sampling in adjunct to forceps biopsy increases the absolute detection rates of Barrett's oesophagus and oesophageal dysplasia: a meta-analysis and systematic review.

Authors:  Vishnu Charan Suresh Kumar; Prateek Harne; Venkata Suresh Patthipati; Abinash Subedi; Umair Masood; Anuj Sharma; Faith Goyal; Nancy Aggarwal; Bishnu Sapkota
Journal:  BMJ Open Gastroenterol       Date:  2020-09

4.  A Rapid Cytological Screening as pre-Endoscopy Screening for Early Esophageal Squamous Cell Lesions: A Prospective Pilot Study from a Chinese Academic Center.

Authors:  Yadong Feng; Yan Liang; Bin Yao; Jiajia Xu; Juncai Zang; Youyu Zhang; Jiong Zhang; Guangpeng Xu; Bo Wei; Xiangyi Yao; Peilin Huang; Ruihua Shi
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.